Abstract
Zebrafish have recently acquired the attention of the research community as a model to study neurological pathologies and behavioural anomalies. The small size and high fecundity have made the zebrafish highly suitable for high-throughput screening. The relatively simple organisation of its nervous system and the optically transparent embryos allow real-time neurological imaging of the zebrafish embryos. Further, genetic malleability and highly varied behavioural repertoire increase its suitability as a model for neurological studies. The recent increase in ageing population and the number of patients suffering with neurodegeneration pose the pressing need for effective models for the study of neurological diseases. The current dearth of therapies for the treatment of neurological disorders is mainly due to the lack of absolute and robust in vivo models. Interestingly, zebrafish models have been found to successfully simulate Alzheimer’s disease (AD) and tauopathy pathologies along with other neurodegenerative conditions. This chapter summarizes the contemporary research studies that employ zebrafish as neurological models for the development of improved translational therapeutic strategies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abramsson A et al (2013) The zebrafish amyloid precursor protein-b is required for motor neuron guidance and synapse formation. Dev Biol 381(2):377–388
Alford S et al (2018) Obesity as a risk factor for Alzheimer's disease: weighing the evidence. Obes Rev 19(2):269–280
Amo R et al (2010) Identification of the zebrafish ventral habenula as a homolog of the mammalian lateral habenula. J Neurosci 30(4):1566–1574
Anichtchik O et al (2008) Loss of PINK1 function affects development and results in neurodegeneration in zebrafish. J Neurosci 28(33):8199–8207
Antinucci P, Hindges R (2016) A crystal-clear zebrafish for in vivo imaging. Sci Rep 6:29490
Aoyama Y et al (2015) A novel method for rearing zebrafish by using freshwater rotifers (Brachionus calyciflorus). Zebrafish 12(4):288–295
Apostolova LG (2016) Alzheimer disease. Continuum (Minneap Minn) 22(2 Dementia):419–434
Avdesh A et al (2012) Regular care and maintenance of a zebrafish (Danio rerio) laboratory: an introduction. J Vis Exp 69:e4196
Bai Q, Burton EA (2011) Zebrafish models of tauopathy. Biochim Biophys Acta 1812(3):353–363
Bai Q et al (2007) Generation of a transgenic zebrafish model of tauopathy using a novel promoter element derived from the zebrafish eno2 gene. Nucleic Acids Res 35(19):6501–6516
Bailey J, Oliveri A, Levin ED (2013) Zebrafish model systems for developmental neurobehavioral toxicology. Birth Defects Res C Embryo Today 99(1):14–23
Baraban SC et al (2005) Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 131(3):759–768
Baraban SC, Dinday MT, Hortopan GA (2013) Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment. Nat Commun 4:2410
Baronio D et al (2018) Embryonic exposure to valproic acid affects the histaminergic system and the social behaviour of adult zebrafish (Danio rerio). Br J Pharmacol 175(5):797–809
Basnet RM et al (2019) Zebrafish larvae as a behavioral model in neuropharmacology. Biomedicine 7(1):23
Becker CG, Becker T (2008) Adult zebrafish as a model for successful central nervous system regeneration. Restor Neurol Neurosci 26(2–3):71–80
Beffagna G (2019) Zebrafish as a smart model to understand regeneration after heart injury: how fish could help humans. Front Cardiovasc Med 6:107
Bekris LM et al (2010) Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol 23(4):213–227
Best JD, Alderton WK (2008) Zebrafish: an in vivo model for the study of neurological diseases. Neuropsychiatr Dis Treat 4(3):567–576
Bhattarai P et al (2017a) Modeling amyloid-beta42 toxicity and neurodegeneration in adult zebrafish brain. J Vis Exp (128):56014
Bhattarai P et al (2017b) The effects of aging on amyloid-β42-induced neurodegeneration and regeneration in adult zebrafish brain. Neurogenesis (Austin) 4(1):e1322666
Bhattarai P et al (2020) Neuron-glia interaction through serotonin-BDNF-NGFR axis enables regenerative neurogenesis in Alzheimer's model of adult zebrafish brain. PLoS Biol 18(1):e3000585
Bondi MW, Edmonds EC, Salmon DP (2017) Alzheimer’s disease: past, present, and future. J Int Neuropsychol Soc 23(9–10):818–831
Bradbury J (2004) Small fish, big science. PLoS Biol 2(5):E148
Bradford YM et al (2017) Zebrafish models of human disease: gaining insight into human disease at ZFIN. ILAR J 58(1):4–16
Braubach OR, Fine A, Croll RP (2012) Distribution and functional organization of glomeruli in the olfactory bulbs of zebrafish (Danio rerio). J Comp Neurol 520(11):2317–2339, Spc1
Bretaud S et al (2007) p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson’s disease. J Neurochem 100(6):1626–1635
Brown K (2017) An interview with Christiane Nüsslein-Volhard. Development 144(21):3851
Bruni G et al (2016) Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds. Nat Chem Biol 12(7):559–566
Burré J et al (2010) Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329(5999):1663–1667
Calvo-Ochoa E, Byrd-Jacobs CA (2019) The olfactory system of zebrafish as a model for the study of neurotoxicity and injury: implications for neuroplasticity and disease. Int J Mol Sci 20(7):1639
Chandra S et al (2004) Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc Natl Acad Sci U S A 101(41):14966–14971
Chege SW et al (2012) Expression and function of KCNQ channels in larval zebrafish. Dev Neurobiol 72(2):186–198
Chen C-M et al (2014) FBXO7 Y52C polymorphism as a potential protective factor in Parkinson's disease. PLoS One 9(7):e101392–e101392
Cheng R-K, Jesuthasan SJ, Penney TB (2014) Zebrafish forebrain and temporal conditioning. Philos Trans R Soc Lond Ser B Biol Sci 369(1637):20120462
Connaughton VP, Nelson R, Bender AM (2008) Electrophysiological evidence of GABAA and GABAC receptors on zebrafish retinal bipolar cells. Vis Neurosci 25(2):139–153
Cowell JK (2014) LGI1: from zebrafish to human epilepsy. Prog Brain Res 213:159–179
Cunvong K et al (2013) Amyloid-β increases capillary bed density in the adult zebrafish retina. Invest Ophthalmol Vis Sci 54(2):1516–1521
Das S, Rajanikant GK (2014) Huntington disease: can a zebrafish trail leave more than a ripple? Neurosci Biobehav Rev 45:258–261
Davis EE, Frangakis S, Katsanis N (2014) Interpreting human genetic variation with in vivo zebrafish assays. Biochim Biophys Acta 1842(10):1960–1970
DeMaagd G, Philip A (2015) Parkinson’s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. P T 40(8):504–532
Dong J, Stuart GW (2004) Transgene manipulation in zebrafish by using recombinases. Methods Cell Biol 77:363–379
Dooley K, Zon LI (2000) Zebrafish: a model system for the study of human disease. Curr Opin Genet Dev 10(3):252–256
Eddins D et al (2010) Zebrafish provide a sensitive model of persisting neurobehavioral effects of developmental chlorpyrifos exposure: comparison with nicotine and pilocarpine effects and relationship to dopamine deficits. Neurotoxicol Teratol 32(1):99–108
Emamzadeh FN, Surguchov A (2018) Parkinson’s disease: biomarkers, treatment, and risk factors. Front Neurosci 12:612
Feng CW et al (2014) Effects of 6-hydroxydopamine exposure on motor activity and biochemical expression in zebrafish (Danio rerio) larvae. Zebrafish 11(3):227–239
Finkbeiner S (2011) Huntington’s disease. Cold Spring Harb Perspect Biol 3(6):a007476
Flinn L et al (2009) Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). Brain 132(6):1613–1623
Furlan G et al (2017) Life-long neurogenic activity of individual neural stem cells and continuous growth establish an outside-in architecture in the teleost pallium. Curr Biol 27(21):3288–3301.e3
Ganz J et al (2014) Subdivisions of the adult zebrafish pallium based on molecular marker analysis. F1000Res 3:308
Gao Y et al (2017) Genetic manipulation in zebrafish. Sheng Wu Gong Cheng Xue Bao 33(10):1674–1692
Geisler R et al (2016) Maintenance of zebrafish lines at the European Zebrafish Resource Center. Zebrafish 13(Suppl 1):S19–S23
Gemberling M et al (2013) The zebrafish as a model for complex tissue regeneration. Trends Genet 29(11):611–620
Gioacchini G et al (2010) Increase of fecundity by probiotic administration in zebrafish (Danio rerio). Reproduction 140(6):953–959
Godoy R et al (2015) Chemogenetic ablation of dopaminergic neurons leads to transient locomotor impairments in zebrafish larvae. J Neurochem 135(2):249–260
Goldsmith JR, Jobin C (2012) Think small: zebrafish as a model system of human pathology. J Biomed Biotechnol 2012:817341
Greten-Harrison B et al (2010) αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc Natl Acad Sci U S A 107(45):19573–19578
Groth C et al (2002) Identification of a second presenilin gene in zebrafish with similarity to the human Alzheimer’s disease gene presenilin2. Dev Genes Evol 212(10):486–490
Guo S (2009) Using zebrafish to assess the impact of drugs on neural development and function. Expert Opin Drug Discovery 4(7):715–726
Gut P et al (2017) Little fish, big data: zebrafish as a model for cardiovascular and metabolic disease. Physiol Rev 97(3):889–938
Gutiérrez-Lovera C et al (2017) The potential of zebrafish as a model organism for improving the translation of genetic anticancer nanomedicines. Genes 8(12):349
Henshall TL et al (2009) Selective neuronal requirement for huntingtin in the developing zebrafish. Hum Mol Genet 18(24):4830–4842
Holtzman NG et al (2016) Learning to fish with genetics: a primer on the vertebrate model Danio rerio. Genetics 203(3):1069–1089
Hoo JY et al (2016) Zebrafish: a versatile animal model for fertility research. Biomed Res Int 2016:9732780
Hortopan GA, Dinday MT, Baraban SC (2010) Spontaneous seizures and altered gene expression in GABA signaling pathways in a mind bomb mutant zebrafish. J Neurosci 30(41):13718–13728
Horzmann KA, Freeman JL (2016) Zebrafish get connected: investigating neurotransmission targets and alterations in chemical toxicity. Toxics 4(3):19
Howe K et al (2013) The zebrafish reference genome sequence and its relationship to the human genome. Nature 496(7446):498–503
Hsieh DJ, Liao CF (2002) Zebrafish M2 muscarinic acetylcholine receptor: cloning, pharmacological characterization, expression patterns and roles in embryonic bradycardia. Br J Pharmacol 137(6):782–792
Hu Q et al (2017) Effects of titanium dioxide nanoparticles exposure on parkinsonism in zebrafish larvae and PC12. Chemosphere 173:373–379
Inamdar NN et al (2007) Parkinson's disease: genetics and beyond. Curr Neuropharmacol 5(2):99–113
Ingham PW (1997) Zebrafish genetics and its implications for understanding vertebrate development. Hum Mol Genet 6(10):1755–1760
Jiang H, Newman M, Lardelli M (2018) The zebrafish orthologue of familial Alzheimer’s disease gene PRESENILIN 2 is required for normal adult melanotic skin pigmentation. PLoS One 13(10):e0206155
Jimenez-Sanchez M et al (2017) Huntington’s disease: mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harbor Perspect Med 7(7):a024240
Kabashi E et al (2011) Zebrafish models for the functional genomics of neurogenetic disorders. Biochim Biophys Acta 1812(3):335–345
Kalueff AV, Stewart AM, Gerlai R (2014) Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol Sci 35(2):63–75
Karlovich CA et al (1998) Characterization of the Huntington's disease (HD) gene homologue in the zebrafish Danio rerio. Gene 217(1–2):117–125
Karlsson J, von Hofsten J, Olsson PE (2001) Generating transparent zebrafish: a refined method to improve detection of gene expression during embryonic development. Mar Biotechnol 3(6):522–527
Kettleborough RNW et al (2013) A systematic genome-wide analysis of zebrafish protein-coding gene function. Nature 496(7446):494–497
Khan KM et al (2017) Zebrafish models in neuropsychopharmacology and CNS drug discovery. Br J Pharmacol 174(13):1925–1944
Kim YH et al (2010) Scopolamine-induced learning impairment reversed by physostigmine in zebrafish. Neurosci Res 67(2):156–161
Kinth P, Mahesh G, Panwar Y (2013) Mapping of zebrafish research: a global outlook. Zebrafish 10(4):510–517
Kizil C et al (2012) Adult neurogenesis and brain regeneration in zebrafish. Dev Neurobiol 72(3):429–461
Klein C, Westenberger A (2012) Genetics of Parkinson’s disease. Cold Spring Harbor Perspect Med 2(1):a008888
Koehler D, Williams FE (2018) Utilizing zebrafish and okadaic acid to study Alzheimer’s disease. Neural Regen Res 13(9):1538–1541
Kundap UP et al (2017) Zebrafish as a model for epilepsy-induced cognitive dysfunction: a pharmacological, biochemical and behavioral approach. Front Pharmacol 8:515
Kyzar EJ et al (2012) Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology. Prog Neuro-Psychopharmacol Biol Psychiatry 37(1):194–202
Lam CS, Korzh V, Strahle U (2005) Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP. Eur J Neurosci 21(6):1758–1762
Leimer U et al (1999) Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis. Biochemistry 38(41):13602–13609
Li M et al (2018) Acteoside protects against 6-OHDA-induced dopaminergic neuron damage via Nrf2-ARE signaling pathway. Food Chem Toxicol 119:6–13
Liu J, Baraban SC (2019) Network properties revealed during multi-scale calcium imaging of seizure activity in zebrafish. eNeuro 6(1):ENEURO.0041-19.2019
Liu J et al (2007) A betaPix Pak2a signaling pathway regulates cerebral vascular stability in zebrafish. Proc Natl Acad Sci U S A 104(35):13990–13995
Lopes da Fonseca T et al (2013) The zebrafish homologue of Parkinson’s disease ATP13A2 is essential for embryonic survival. Brain Res Bull 90:118–126
Lulla A et al (2016) Neurotoxicity of the Parkinson disease-associated pesticide ziram is synuclein-dependent in zebrafish embryos. Environ Health Perspect 124(11):1766–1775
Lumsden AL et al (2007) Huntingtin-deficient zebrafish exhibit defects in iron utilization and development. Hum Mol Genet 16(16):1905–1920
Makhija DT, Jagtap AG (2014) Studies on sensitivity of zebrafish as a model organism for Parkinson's disease: comparison with rat model. J Pharmacol Pharmacother 5(1):39–46
Martin B et al (2005) Class II G protein-coupled receptors and their ligands in neuronal function and protection. NeuroMolecular Med 7(1–2):3–36
Matsui H, Sugie A (2017) An optimized method for counting dopaminergic neurons in zebrafish. PLoS One 12(9):e0184363
McKinley ET et al (2005) Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Brain Res Mol Brain Res 141(2):128–137
Meshalkina DA et al (2017) Adult zebrafish in CNS disease modeling: a tank that's half-full, not half-empty, and still filling. Lab Anim (NY) 46(10):378–387
Mueller T (2012) What is the thalamus in zebrafish? Front Neurosci 6:64
Mueller T et al (2011) The dorsal pallium in zebrafish, Danio rerio (Cyprinidae, Teleostei). Brain Res 1381:95–105
Myers RH (2004) Huntington’s disease genetics. NeuroRx 1(2):255–262
Nakano N et al (2017) PI3K/AKT signaling mediated by G proteincoupled receptors is involved in neurodegenerative Parkinson’s disease (review). Int J Mol Med 39(2):253–260
Neelkantan N et al (2013) Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds. ACS Chem Neurosci 4(8):1137–1150
Nellore J, Nandita P (2015) Paraquat exposure induces behavioral deficits in larval zebrafish during the window of dopamine neurogenesis. Toxicol Rep 2:950–956
Nery LR et al (2017) Presenilin-1 targeted morpholino induces cognitive deficits, increased brain Aβ1−42 and decreased synaptic marker PSD-95 in zebrafish larvae. Neurochem Res 42(10):2959–2967
Neueder A et al (2017) The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington's disease patients. Sci Rep 7(1):1307
Neugroschl J, Wang S (2011) Alzheimer’s disease: diagnosis and treatment across the spectrum of disease severity. Mt Sinai J Med 78(4):596–612
Newman M, Ebrahimie E, Lardelli M (2014) Using the zebrafish model for Alzheimer's disease research. Front Genet 5:189–189
Nopoulos PC (2016) Huntington disease: a single-gene degenerative disorder of the striatum. Dialogues Clin Neurosci 18(1):91–98
Nüsslein-Volhard C (2012) The zebrafish issue of development. Development 139(22):4099
Okamoto H, Agetsuma M, Aizawa H (2012) Genetic dissection of the zebrafish habenula, a possible switching board for selection of behavioral strategy to cope with fear and anxiety. Dev Neurobiol 72(3):386–394
Panula P et al (2006) Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases. Zebrafish 3(2):235–247
Paquet D et al (2009) A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J Clin Invest 119(5):1382–1395
Parng C et al (2002) Zebrafish: a preclinical model for drug screening. Assay Drug Dev Technol 1(1 Pt 1):41–48
Patowary A et al (2013) A sequence-based variation map of zebrafish. Zebrafish 10(1):15–20
Pegueroles J et al (2018) Obesity and Alzheimer’s disease, does the obesity paradox really exist? A magnetic resonance imaging study. Oncotarget 9(78):34691–34698
Prabhudesai S et al (2012) A novel “molecular tweezer” inhibitor of α-synuclein neurotoxicity in vitro and in vivo. Neurotherapeutics 9(2):464–476
Prabhudesai S et al (2016) LRRK2 knockdown in zebrafish causes developmental defects, neuronal loss, and synuclein aggregation. J Neurosci Res 94(8):717–735
Ramkumar M et al (2018) Demethoxycurcumin, a natural derivative of curcumin abrogates rotenone-induced dopamine depletion and motor seficits by its antioxidative and anti-inflammatory properties in parkinsonian rats. Pharmacogn Mag 14(53):9–16
Ren G et al (2011) Disruption of LRRK2 does not cause specific loss of dopaminergic neurons in zebrafish. PLoS One 6(6):e20630–e20630
Rico EP et al (2011) Zebrafish neurotransmitter systems as potential pharmacological and toxicological targets. Neurotoxicol Teratol 33(6):608–617
Rizek P, Kumar N, Jog MS (2016) An update on the diagnosis and treatment of Parkinson disease. CMAJ 188(16):1157–1165
Roos RA (2010) Huntington’s disease: a clinical review. Orphanet J Rare Dis 5:40
Saleem S, Kannan RR (2018) Zebrafish: an emerging real-time model system to study Alzheimer’s disease and neurospecific drug discovery. Cell Death Dis 4:45
Sallinen V et al (2010) Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish. Neurobiol Dis 40(1):93–101
Santana S, Rico EP, Burgos JS (2012) Can zebrafish be used as animal model to study Alzheimer’s disease? Am J Neurodegener Dis 1(1):32–48
Santoriello C, Zon LI (2012) Hooked! Modeling human disease in zebrafish. J Clin Invest 122(7):2337–2343
Sarath Babu N et al (2016) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease in zebrafish. Proteomics 16(9):1407–1420
Savio LE et al (2012) Behavioral changes induced by long-term proline exposure are reversed by antipsychotics in zebrafish. Prog Neuro-Psychopharmacol Biol Psychiatry 36(2):258–263
Schachter AS, Davis KL (2000) Alzheimer’s disease. Dialogues Clin Neurosci 2(2):91–100
Schiffer NW et al (2007) Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model. J Biol Chem 282(12):9195–9203
Schmidt R, Strähle U, Scholpp S (2013) Neurogenesis in zebrafish—from embryo to adult. Neural Dev 8:3
Schubert J et al (2014) Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes. Nat Genet 46(12):1327–1332
Seibt KJ et al (2011) Antipsychotic drugs reverse MK-801-induced cognitive and social interaction deficits in zebrafish (Danio rerio). Behav Brain Res 224(1):135–139
Singleman C, Holtzman NG (2014) Growth and maturation in the zebrafish, Danio rerio: a staging tool for teaching and research. Zebrafish 11(4):396–406
Skaggs K, Goldman D, Parent JM (2014) Excitotoxic brain injury in adult zebrafish stimulates neurogenesis and long-distance neuronal integration. Glia 62(12):2061–2079
Song P, Pimplikar SW (2012) Knockdown of amyloid precursor protein in zebrafish causes defects in motor axon outgrowth. PLoS One 7(4):e34209–e34209
Spitsbergen JM, Kent ML (2003) The state of the art of the zebrafish model for toxicology and toxicologic pathology research—advantages and current limitations. Toxicol Pathol 31(Suppl):62–87
Stehr CM et al (2006) The developmental neurotoxicity of fipronil: notochord degeneration and locomotor defects in zebrafish embryos and larvae. Toxicol Sci 92(1):270–278
Stewart A et al (2012) Modeling anxiety using adult zebrafish: a conceptual review. Neuropharmacology 62(1):135–143
Suls A et al (2013) De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome. Am J Hum Genet 93(5):967–975
Swarthout JT, Raisinghani M, Cui X (2011) Zinc finger nucleases: a new era for transgenic animals. Ann Neurosci 18(1):25–28
Teng Y et al (2010) Knockdown of zebrafish Lgi1a results in abnormal development, brain defects and a seizure-like behavioral phenotype. Hum Mol Genet 19(22):4409–4420
Tiedeken JA, Ramsdell JS (2007) Embryonic exposure to domoic acid increases the susceptibility of zebrafish larvae to the chemical convulsant pentylenetetrazole. Environ Health Perspect 115(11):1547–1552
Timme-Laragy AR, Karchner SI, Hahn ME (2012) Gene knockdown by morpholino-modified oligonucleotides in the zebrafish (Danio rerio) model: applications for developmental toxicology. Methods Mol Biol 889:51–71
Turner KJ et al (2016) Afferent connectivity of the zebrafish habenulae. Front Neural Circuits 10:30
Ünal İ et al (2019) Rotenone impairs oxidant/antioxidant balance both in brain and intestines in zebrafish. Int J Neurosci 129(4):363–368
Ung CY et al (2015) Mosaic zebrafish transgenesis for functional genomic analysis of candidate cooperative genes in tumor pathogenesis. J Vis Exp (97):52567
van Bebber F et al (2013) Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes. J Neurochem 127(4):471–481
Varga M et al (2018) Zebrafish models of rare hereditary pediatric diseases. Diseases 6(2):43
Vaz RL, Outeiro TF, Ferreira JJ (2018) Zebrafish as an animal model for rrug discovery in Parkinson’s disease and other movement disorders: a systematic review. Front Neurol 9:347
Vijayanathan Y et al (2017) 6-OHDA-lesioned adult zebrafish as a useful Parkinson’s disease model for dopaminergic neuroregeneration. Neurotox Res 32(3):496–508
Vogel G (2000) GENOMICS: Sanger will sequence zebrafish genome. Science 290(5497):1671b
Wafer LN et al (2016) Effects of environmental enrichment on the fertility and fecundity of zebrafish (Danio rerio). J Am Assoc Lab Anim Sci 55(3):291–294
Wang M et al (2011) Eriocaulon buergerianum extract protects PC12 cells and neurons in zebrafish against 6-hydroxydopamine-induced damage. Chin Med 6(1):16
Wang L et al (2016) DNA methylation regulates gabrb2 mRNA expression: developmental variations and disruptions in l-methionine-induced zebrafish with schizophrenia-like symptoms. Genes Brain Behav 15(8):702–710
Weller J, Budson A (2018) Current understanding of Alzheimer’s disease diagnosis and treatment. F1000Res 7:F1000 Faculty Rev-1161
Wiatr K et al (2018) Huntington disease as a neurodevelopmental disorder and early signs of the disease in stem cells. Mol Neurobiol 55(4):3351–3371
Wilson L, Lardelli M (2013) The development of an in vivo γ-secretase assay using zebrafish embryos. J Alzheimers Dis 36(3):521–534
Wilson SW, Brand M, Eisen JS (2002) Patterning the zebrafish central nervous system. Results Probl Cell Differ 40:181–215
Woods IG et al (2000) A comparative map of the zebrafish genome. Genome Res 10(12):1903–1914
Wu B-K et al (2016) Multiple signaling factors and drugs alleviate neuronal death induced by expression of human and zebrafish tau proteins in vivo. J Biomed Sci 23:25
Xia W (2010) Exploring Alzheimer's disease in zebrafish. J Alzheimers Dis 20(4):981–990
Xiong Y, Dawson TM, Dawson VL (2017) Models of LRRK2-associated Parkinson’s disease. Adv Neurobiol 14:163–191
Xu Z, Cheng XE (2017) Zebrafish tracking using convolutional neural networks. Sci Rep 7:42815
Yang X et al (2017) Effects of picrotoxin on zebrafish larvae behaviors: a comparison study with PTZ. Epilepsy Behav 70(Pt A):224–231
Zakhary SM et al (2011) A behavioral and molecular analysis of ketamine in zebrafish. Synapse 65(2):160–167
Zdebik AA et al (2013) Epilepsy in kcnj10 morphant zebrafish assessed with a novel method for long-term EEG recordings. PLoS One 8(11):e79765
Zhang X et al (2013) An over expression APP model for anti-Alzheimer disease drug screening created by zinc finger nuclease technology. PLoS One 8(11):e75493
Zhang LQ et al (2015a) Schisantherin A protects against 6-OHDA-induced dopaminergic neuron damage in zebrafish and cytotoxicity in SH-SY5Y cells through the ROS/NO and AKT/GSK3β pathways. J Ethnopharmacol 170:8–15
Zhang Y et al (2015b) Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine. PLoS One 10(5):e0125898
Zhang X-f, Thompson M, Xu Y-H (2016) Multifactorial theory applied to the neurotoxicity of paraquat and paraquat-induced mechanisms of developing Parkinson’s disease. Lab Investig 96(5):496–507
Acknowledgement
The authors acknowledge the financial support from the DBT-RA Program in Biotechnology and Life Sciences and DBT-Nanobiotechnology Program (San. No. BT/PR6765/NNT/28/618/2012), Government of India.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Saleem, S., Kannan, R.R. (2022). Zebrafish: A Potential Preclinical Model for Neurological Research in Modern Biology. In: Bhandari, P.R., Bharani, K.K., Khurana, A. (eds) Zebrafish Model for Biomedical Research . Springer, Singapore. https://doi.org/10.1007/978-981-16-5217-2_14
Download citation
DOI: https://doi.org/10.1007/978-981-16-5217-2_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-5216-5
Online ISBN: 978-981-16-5217-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)